Wealth Quarterback’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330K Buy
2,367
+12
+0.5% +$1.68K 0.13% 121
2025
Q4
$289K Buy
2,355
+1
+0% +$122 0.1% 127
2025
Q3
$261K Buy
2,354
+15
+0.6% +$1.71K 0.1% 135
2025
Q2
$259K Sell
2,339
-18
-0.8% -$1.92K 0.12% 117
2025
Q1
$264K Sell
2,357
-15
-0.6% -$1.55K 0.15% 108
2024
Q4
$219K Buy
+2,372
New +$214K 0.1% 109
2023
Q4
Sell
-2,903
Closed -$218K 122
2023
Q3
$218K Sell
2,903
-197
-6% -$15.2K 0.19% 98
2023
Q2
$239K Sell
3,100
-759
-20% -$60.5K 0.17% 98
2023
Q1
$320K Sell
3,859
-114
-3% -$9.44K 0.27% 75
2022
Q4
$341K Buy
3,973
+239
+6% +$18.9K 0.28% 77
2022
Q3
$230K Sell
3,734
-40
-1% -$2.52K 0.24% 86
2022
Q2
$233K Buy
+3,774
New +$234K 0.18% 98
2021
Q3
$271K Buy
10,142
+6,043
+147% +$425K 0.18% 93
2021
Q2
$283K Buy
+4,099
New +$274K 0.17% 91
2020
Q4
$240K Sell
4,113
-1,701
-29% -$103K 0.2% 94
2020
Q3
$447K Hold
5,814
0.41% 66
2020
Q2
$447K Sell
5,814
-2,447
-30% -$188K 0.41% 66
2020
Q1
$549K Sell
8,261
-122,678
-94% -$8.48M 0.5% 43
2019
Q4
$589K Buy
+130,939
New +$8.53M 0.51% 45

Other funds holding GILD

Wealth Quarterback's GILD Position: Q1 2026 in Review

Wealth Quarterback increased its Gilead Sciences (GILD) stake by 0.51% in Q1 2026, buying an estimated $1.68K and bringing the position to 2,367 shares worth $330K. The position accounts for 0.13% of the portfolio, ranked #121.

Wealth Quarterback first reported a position in GILD in Q4 2019 and has held it in 19 quarters since. The position peaked at $589K in Q4 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Wealth Quarterback held 2,367 shares of Gilead Sciences worth $330K as of Q1 2026.
  • Wealth Quarterback bought 12 Gilead Sciences shares in Q1 2026, an estimated $1.68K.
  • Gilead Sciences made up 0.13% of Wealth Quarterback's portfolio in Q1 2026, its #121 holding.
  • Wealth Quarterback first reported a position in Gilead Sciences in Q4 2019 and has held it in 19 quarters since.
  • Wealth Quarterback's Gilead Sciences position peaked at $589K in Q4 2019.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wealth Quarterback's 13F filing for Q1 2026, filed 9 Apr 2026.